Key points are not available for this paper at this time.
Covering: up to 2010 The myxobacteria, long a source of fascination due to their sophisticated, social lifestyles, are now increasingly recognized as multi-producers of promising natural products. Here we provide an overview of the bioactivities and modes-of-action of these secondary metabolites, with an emphasis on potential clinical applications.
Weissman et al. (2010) studied this question.